R. Sridhara

1.1k total citations
24 papers, 862 citations indexed

About

R. Sridhara is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, R. Sridhara has authored 24 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Molecular Biology. Recurrent topics in R. Sridhara's work include Advanced Breast Cancer Therapies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Treatment and Pharmacology (3 papers). R. Sridhara is often cited by papers focused on Advanced Breast Cancer Therapies (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Cancer Treatment and Pharmacology (3 papers). R. Sridhara collaborates with scholars based in United States, Sweden and Australia. R. Sridhara's co-authors include Richard Pazdur, Leonard Reyno, Merrill J. Egorin, Y Tong, CA Schiffer, Patricia Keegan, Victoria J. Sinibaldi, Mario A. Eisenberger, Eleanor G. Zuhowski and Duncan I. Jodrell and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

R. Sridhara

23 papers receiving 826 citations

Peers

Countries citing papers authored by R. Sridhara

Since Specialization

Citations

This map shows the geographic impact of R. Sridhara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Sridhara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Sridhara more than expected).

Fields of papers citing papers by R. Sridhara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Sridhara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Sridhara. The network helps show where R. Sridhara may publish in the future.

Co-authorship network of co-authors of R. Sridhara

This figure shows the co-authorship network connecting the top 25 collaborators of R. Sridhara. A scholar is included among the top collaborators of R. Sridhara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Sridhara. R. Sridhara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Collision-Free Trajectory Planning of Mobile Robots by Integrating Deep Reinforcement Learning and Model Predictive Control 2023 ·Chalmers Research (Chalmers University of Technology) ·Ze Zhang, Yao Cai, (unknown), (unknown), (unknown), (unknown), R. Sridhara, Knut Åkesson	2
2	External control arms in oncology: current use and future directions 2022 ·Annals of Oncology ·Pallavi S. Mishra‐Kalyani, (unknown), Donna R. Rivera, Harpreet Singh, Amna Ibrahim, (unknown), Yuan Li Shen, Shenghui Tang, R. Sridhara, Paul G. Kluetz, John Concato, Richard Pazdur, Julia A. Beaver	78
3	A Food and Drug Administration analysis of survival outcomes comparing the Adjuvant Paclitaxel and Trastuzumab trial with an external control from historical clinical trials 2020 ·Annals of Oncology ·Laleh Amiri‐Kordestani, Diqiong Xie, Sara M. Tolaney, Erik Bloomquist, Shenghui Tang, Amna Ibrahim, Kirsten B. Goldberg, Marc R. Theoret, Richard Pazdur, R. Sridhara, Eric P. Winer, Julia A. Beaver	15
4	Abstract GS5-06: A U.S. food and drug administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapy 2018 ·Cancer Research ·Harpreet Singh, (unknown), Erik Bloomquist, Suparna Wedam, Laleh Amiri‐Kordestani, Shenghui Tang, R. Sridhara, Amna Ibrahim, Kirsten B. Goldberg, Amy S. McKee, (unknown), Richard Pazdur	10
5	Exploratory analysis of the association of depth of response and survival in patients with metastatic non-small-cell lung cancer treated with a targeted therapy or immunotherapy 2017 ·Annals of Oncology ·Caroline E. McCoach, Gideon M. Blumenthal, (unknown), Adrian Myers, Shenghui Tang, R. Sridhara, Patricia Keegan, Richard Pazdur, Robert C. Doebele, Dickran Kazandjian	63
6	Relationship between OS and PFS in metastatic breast cancer (MBC): Review of FDA submission data. 2011 ·Journal of Clinical Oncology ·Patricia Cortazar, (unknown), R. Sridhara, Robert Justice, Richard Pazdur	10
7	Review of Oncology and Hematology Drug Product Approvals at the US Food and Drug Administration Between July 2005 and December 2007 2010 ·JNCI Journal of the National Cancer Institute ·R. Sridhara, John R. Johnson, Robert Justice, Patricia Keegan, (unknown), Richard Pazdur	76
8	Use of progression-free survival (PFS) as an endpoint in advanced non-small cell lung cancer (NSCLC) trials: FDA perspective. 2010 ·Journal of Clinical Oncology ·Simran Malik, (unknown), R. Sridhara, Robert Justice, Richard Pazdur	2
9	Challenges to Use of Health-Related Quality of Life for Food and Drug Administration Approval of Anticancer Products 2007 ·JNCI Monographs ·Edwin P. Rock, Jane Scott, Dianne L. Kennedy, R. Sridhara, Richard Pazdur, Laurie B. Burke	23
10	The relationship between the duration of platelet storage and the development of transfusion reactions 1998 ·Transfusion ·C Sarkodee-Adoo, Jason Kendall, R. Sridhara, (unknown), CA Schiffer	66
11	Plasma concentrations and pharmacokinetics of dimethylsulfoxide and its metabolites in patients undergoing peripheral-blood stem-cell transplants. 1998 ·Journal of Clinical Oncology ·Merrill J. Egorin, Dina Rosen, R. Sridhara, LL Sensenbrenner, Michele Cottler‐Fox	28
12	Tandem autotransplantation for the treatment of metastatic breast cancer. 1995 ·Journal of Clinical Oncology ·E. Randolph Broun, R. Sridhara, George W. Sledge, Danuta Z. Loesch, (unknown), (unknown), Robert Hromas, Kenneth Cornetta, Lawrence H. Einhorn	29
13	Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer. 1995 ·Journal of Clinical Oncology ·Mario A. Eisenberger, Victoria J. Sinibaldi, Leonard Reyno, R. Sridhara, Duncan I. Jodrell, Eleanor G. Zuhowski, Katherine H. R. Tkaczuk, Mark H. Lowitt, Ramzi K. Hemady, S. Jacobs	66
14	Development and validation of a pharmacokinetically based fixed dosing scheme for suramin. 1995 ·Journal of Clinical Oncology ·Leonard Reyno, Merrill J. Egorin, Mario A. Eisenberger, Victoria J. Sinibaldi, Eleanor G. Zuhowski, R. Sridhara	47
15	Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer. 1994 ·Journal of Clinical Oncology ·Duncan I. Jodrell, Leonard Reyno, R. Sridhara, Mario A. Eisenberger, Katherine H. R. Tkaczuk, Eleanor G. Zuhowski, Victoria J. Sinibaldi, Matjaž Novak, Merrill J. Egorin	42
16	Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor EL 1994 ·Blood ·DD Ross, (unknown), Y Tong, Brian Cornblatt, (unknown), R. Sridhara, EJ Lee, CA Schiffer	49
17	Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer. 1993 ·Journal of Clinical Oncology ·Leonard Reyno, Merrill J. Egorin, Renzo Canetta, Duncan I. Jodrell, K. Swenerton, J Pater, James N. Burroughs, Matjaž Novak, R. Sridhara	27
18	Enhancement of daunorubicin accumulation, retention, and cytotoxicity by verapamil or cyclosporin A in blast cells from patients with previously untreated acute myeloid leukemia 1993 ·Blood ·DD Ross, (unknown), R. Sridhara, (unknown), EJ Lee, CA Schiffer	7
19	Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. 1992 ·PubMed ·Yixuan Huang, (unknown), Patricia L. Blount, (unknown), Jieyun Yin, Y Tong, (unknown), Carnell Newkirk, James H. Resau, R. Sridhara, Brian J. Reid, Stephen J. Meltzer	190
20	Inference on system parameters in a model for interacting species 1990 ·Journal of Mathematical Biology ·R. Sridhara	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact